isoxazoles has been researched along with Osteogenic Sarcoma in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, F; Geng, Z; Hu, L; Huang, Q; Li, X; Liu, S; Liu, X; Song, Q; Wang, H; Yin, Q; Zhu, Y | 1 |
| Tao, J; Wu, B; Xing, C | 1 |
| Gaivão, I; Lemos, S; Ludovico, P; Martins, G; Oliveira, P; Palmeira, C; Peixoto, F; Pinto-Leite, R; Sampaio-Marques, B | 1 |
| Gunosewoyo, H; Jia, KH; Luo, J; Shi, JJ; Sun, H; Tang, J; Yang, F; Yu, LF | 1 |
| Bui, MM; Chu, B; Fu, W; Ma, L; Pledger, WJ; Reed, D; Sharma, SS | 1 |
| Massey, AJ | 1 |
| Avioli, LV; Civitelli, R; Halstead, LR; Hruska, KA; Reid, IR | 1 |
7 other study(ies) available for isoxazoles and Osteogenic Sarcoma
| Article | Year |
|---|---|
VE-822, a novel DNA Holliday junction stabilizer, inhibits homologous recombination repair and triggers DNA damage response in osteogenic sarcomas.
Topics: Antineoplastic Agents; Cell Line, Tumor; DNA; DNA Damage; DNA Repair; Doxorubicin; Humans; Isoxazoles; Osteosarcoma; Pyrazines; Recombination, Genetic | 2021 |
Upregulation of microRNA-23b-3p induced by farnesoid X receptor regulates the proliferation and apoptosis of osteosarcoma cells.
Topics: Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cyclin G1; Humans; Isoxazoles; MicroRNAs; Osteoblasts; Osteosarcoma; Real-Time Polymerase Chain Reaction; Receptors, Cytoplasmic and Nuclear; Up-Regulation | 2019 |
Elucidating the mechanisms of action of parecoxib in the MG-63 osteosarcoma cell line.
Topics: Apoptosis; Bone Neoplasms; Cell Cycle; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Humans; Isoxazoles; Osteosarcoma; Tumor Cells, Cultured | 2020 |
Synthesis and Pharmacological Evaluation of σ2 Receptor Ligands Based on a 3-Alkoxyisoxazole Scaffold: Potential Antitumor Effects against Osteosarcoma.
Topics: Antineoplastic Agents; Apoptosis; Bone Neoplasms; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Isoxazoles; Ligands; Molecular Structure; Osteosarcoma; Receptors, sigma; Structure-Activity Relationship; Tumor Cells, Cultured | 2021 |
Apoptosis of osteosarcoma cultures by the combination of the cyclin-dependent kinase inhibitor SCH727965 and a heat shock protein 90 inhibitor.
Topics: Apoptosis; bcl-2-Associated X Protein; Bone Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Cell Cycle; Cell Line, Tumor; Cyclic N-Oxides; Cyclin-Dependent Kinases; Cytosol; Drug Synergism; Gene Expression Regulation, Neoplastic; HSP90 Heat-Shock Proteins; Humans; Indolizines; Isoxazoles; Mitochondria; Osteosarcoma; Protein Kinase Inhibitors; Protein Transport; Pyridinium Compounds; Resorcinols; Signal Transduction | 2013 |
Inhibition of ATR-dependent feedback activation of Chk1 sensitises cancer cells to Chk1 inhibitor monotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Bone Neoplasms; Cell Proliferation; Checkpoint Kinase 1; Colorectal Neoplasms; DNA Damage; DNA-Activated Protein Kinase; Dose-Response Relationship, Drug; Histones; HT29 Cells; Humans; Indoles; Isoxazoles; Molecular Targeted Therapy; Nuclear Proteins; Osteosarcoma; Protein Kinase Inhibitors; Pyrazines; Pyridones; Signal Transduction; Time Factors | 2016 |
Membrane potential and cation content of osteoblast-like cells (UMR 106) assessed by fluorescent dyes.
Topics: Animals; Barbiturates; Cations; Cell Line; Electrophysiology; Fluorescent Dyes; Hydrogen-Ion Concentration; Intracellular Fluid; Isoxazoles; Membrane Potentials; Osteoblasts; Osteosarcoma; Oxazoles; Rats | 1987 |